APA Style
Melek, N. A. , Melek, N. A. Allam, M. F. , Allam, M. F. Labib, B. G. , Labib, B. G. Bazazo, A. , Bazazo, A. Mahmoud, M. M. , & Mahmoud, M. M. (2023). Differential Complete Blood Count for Diagnosis of COVID-19?.
Current Research in Public Health, 2(1), 50-57.
https://doi.org/10.31586/wjmm.2023.689
ACS Style
Melek, N. A. ; Melek, N. A. Allam, M. F. ; Allam, M. F. Labib, B. G. ; Labib, B. G. Bazazo, A. ; Bazazo, A. Mahmoud, M. M. ; Mahmoud, M. M. Differential Complete Blood Count for Diagnosis of COVID-19?.
Current Research in Public Health 2023 2(1), 50-57.
https://doi.org/10.31586/wjmm.2023.689
Chicago/Turabian Style
Melek, Nermine A., Nermine A. Melek. Mohamed F. Allam, Mohamed F. Allam. Bassem G. Labib, Bassem G. Labib. Abdalla Bazazo, Abdalla Bazazo. Mayada M. Mahmoud, and Mayada M. Mahmoud. 2023. "Differential Complete Blood Count for Diagnosis of COVID-19?".
Current Research in Public Health 2, no. 1: 50-57.
https://doi.org/10.31586/wjmm.2023.689
AMA Style
Melek NA, Melek NAAllam MF, Allam MFLabib BG, Labib BGBazazo A, Bazazo AMahmoud MM, Mahmoud MM. Differential Complete Blood Count for Diagnosis of COVID-19?.
Current Research in Public Health. 2023; 2(1):50-57.
https://doi.org/10.31586/wjmm.2023.689
@Article{crph689,
AUTHOR = {Melek, Nermine A. and Allam, Mohamed F. and Labib, Bassem G. and Bazazo, Abdalla and Mahmoud, Mayada M. and Zeada, Omneya M.},
TITLE = {Differential Complete Blood Count for Diagnosis of COVID-19?},
JOURNAL = {Current Research in Public Health},
VOLUME = {2},
YEAR = {2023},
NUMBER = {1},
PAGES = {50-57},
URL = {https://www.scipublications.com/journal/index.php/WJMM/article/view/689},
ISSN = {2831-5162},
DOI = {10.31586/wjmm.2023.689},
ABSTRACT = {Background: The World Health Organization (WHO) has declared COVID-19 a public health emergency of international concern. In this context, effective and affordable diagnostic procedures are essential for identifying and managing cases. Complete blood counts (CBC) are among the most common and readily available diagnostic tests. The current study aimed to evaluate the efficacy of CBC in diagnosing COVID-19 and identifying cases. Patients and Methods: A case-control study was conducted on 173 patients at Ain Shams University Hospitals over a period of three months. Patients were allocated into two groups according to COVID-19 PCR results: Group 1 included patients with COVID-19 positive PCR, and Group 2 included patients with COVID-19 negative PCR. Results: The study found that differential CBC had significant value in diagnosing COVID-19 disease. Many COVID-19 patients had lymphopenia and leucopenia compared to non-COVID-19 suspected patients. The low values of leukocytes, neutrophils, lymphocytes, and eosinophils with a CBC test were found to be valuable in the initial diagnosis of COVID-19. Conclusion: The definitive diagnosis of COVID-19 requires RT-PCR analysis, which is time-consuming and less accessible. Thus, the initial diagnosis and treatment of patients may be delayed. This study suggests that CBC, which is easily available and affordable, can be valuable in the early identification of COVID-19 cases, allowing for prompt treatment and management.},
}
%0 Journal Article
%A Melek, Nermine A.
%A Allam, Mohamed F.
%A Labib, Bassem G.
%A Bazazo, Abdalla
%A Mahmoud, Mayada M.
%A Zeada, Omneya M.
%D 2023
%J Current Research in Public Health
%@ 2831-5162
%V 2
%N 1
%P 50-57
%T Differential Complete Blood Count for Diagnosis of COVID-19?
%M doi:10.31586/wjmm.2023.689
%U https://www.scipublications.com/journal/index.php/WJMM/article/view/689
TY - JOUR
AU - Melek, Nermine A.
AU - Allam, Mohamed F.
AU - Labib, Bassem G.
AU - Bazazo, Abdalla
AU - Mahmoud, Mayada M.
AU - Zeada, Omneya M.
TI - Differential Complete Blood Count for Diagnosis of COVID-19?
T2 - Current Research in Public Health
PY - 2023
VL - 2
IS - 1
SN - 2831-5162
SP - 50
EP - 57
UR - https://www.scipublications.com/journal/index.php/WJMM/article/view/689
AB - Background: The World Health Organization (WHO) has declared COVID-19 a public health emergency of international concern. In this context, effective and affordable diagnostic procedures are essential for identifying and managing cases. Complete blood counts (CBC) are among the most common and readily available diagnostic tests. The current study aimed to evaluate the efficacy of CBC in diagnosing COVID-19 and identifying cases. Patients and Methods: A case-control study was conducted on 173 patients at Ain Shams University Hospitals over a period of three months. Patients were allocated into two groups according to COVID-19 PCR results: Group 1 included patients with COVID-19 positive PCR, and Group 2 included patients with COVID-19 negative PCR. Results: The study found that differential CBC had significant value in diagnosing COVID-19 disease. Many COVID-19 patients had lymphopenia and leucopenia compared to non-COVID-19 suspected patients. The low values of leukocytes, neutrophils, lymphocytes, and eosinophils with a CBC test were found to be valuable in the initial diagnosis of COVID-19. Conclusion: The definitive diagnosis of COVID-19 requires RT-PCR analysis, which is time-consuming and less accessible. Thus, the initial diagnosis and treatment of patients may be delayed. This study suggests that CBC, which is easily available and affordable, can be valuable in the early identification of COVID-19 cases, allowing for prompt treatment and management.
DO - Differential Complete Blood Count for Diagnosis of COVID-19?
TI - 10.31586/wjmm.2023.689
ER -
